GSK 2793660

CAS No. 1613458-79-9

GSK 2793660( GSK2793660 | GSK-2793660 )

Catalog No. M12343 CAS No. 1613458-79-9

GSK 2793660(GSK2793660) is a potent, selective, irreversible and orally bioavailable cathepsin C inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 In Stock
50MG 1782 In Stock
100MG 2250 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GSK 2793660
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK 2793660(GSK2793660) is a potent, selective, irreversible and orally bioavailable cathepsin C inhibitor.
  • Description
    GSK 2793660(GSK2793660) is a potent, selective, irreversible and orally bioavailable cathepsin C inhibitor, but not the activity of downstream neutrophil serine proteases, for the treatment of cystic fibrosis, non-cystic fibrosis bronchiectasis, ANCA-associated vasculitis and bronchiectasis.Other Indication Phase 1 Discontinued.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    GSK2793660 | GSK-2793660
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Cathepsin
  • Recptor
    Cathepsin
  • Research Area
    Other Indications
  • Indication
    Other Disease

Chemical Information

  • CAS Number
    1613458-79-9
  • Formula Weight
    421.966
  • Molecular Formula
    C22H32ClN3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(C1(N)CCOCC1)N[C@@H](CC(C)C)/C=C/C(N2CCC3=C2C=CC=C3)=O.[H]Cl
  • Chemical Name
    (S,E)-4-amino-N-(1-(indolin-1-yl)-6-methyl-1-oxohept-2-en-4-yl)tetrahydro-2H-pyran-4-carboxamide hydrochloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Miller BE, et al. Br J Clin Pharmacol. 2017 Dec;83(12):2813-2820. 2. Szcze?niak P, et al. J Org Chem. 2016 Feb 5;81(3):1057-74.
molnova catalog
related products
  • L 873724

    L 873724 is a potent and selective non-basic cathepsin K inhibitor with IC50 of 0.2 nM.

  • Odanacatib

    A potent, selective, reversible and orally active cathepsin K inhibitor with IC50 of 0.2 nM.

  • Relacatib

    Relacatib (SB-462795, GSK-462795) is a potent and orally bioavailable small molecule cathepsin inhibitor with Ki of 41, 68 and 53 pM for cathepsin K, L and V, respectively.